BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6508320)

  • 1. [Spergualin a novel antitumor antibiotic produced by Bacillus laterosporus].
    Takeuchi T
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2633-9. PubMed ID: 6508320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spergualin: a new antitumour antibiotic.
    Umezawa K; Takeuchi T
    Biomed Pharmacother; 1987; 41(5):227-32. PubMed ID: 3499181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Spergualin, a new antitumor antibiotic].
    Takeuchi T
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):845-9. PubMed ID: 3566295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of cytotoxic T-lymphocytes in the antitumor activity of spergualin against L1210 cells.
    Umezawa H; Nishikawa K; Shibasaki C; Takahashi K; Nakamura T; Takeuchi T
    Cancer Res; 1987 Jun; 47(12):3062-5. PubMed ID: 3495325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of spergualin, a novel antitumor antibiotic.
    Nishikawa K; Shibasaki C; Takahashi K; Nakamura T; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1986 Oct; 39(10):1461-6. PubMed ID: 3781914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antitumor activity of spergualin analogues. I. Chemical modification of 7-guanidino-3-hydroxyacyl moiety.
    Umeda Y; Moriguchi M; Kuroda H; Nakamura T; Iinuma H; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1985 Jul; 38(7):886-98. PubMed ID: 4030502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunomodulation by antitumor antibiotics].
    Ishizuka M
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):697-700. PubMed ID: 3963840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new antitumor antibiotic, spergualin: isolation and antitumor activity.
    Takeuchi T; Iinuma H; Kunimoto S; Masuda T; Ishizuka M; Takeuchi M; Hamada M; Naganawa H; Kondo S; Umezawa H
    J Antibiot (Tokyo); 1981 Dec; 34(12):1619-21. PubMed ID: 7333976
    [No Abstract]   [Full Text] [Related]  

  • 9. Cytotoxicity of spergualin and amine oxidase activity in medium.
    Kunimoto S; Miura K; Iinuma H; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1985 Jul; 38(7):899-903. PubMed ID: 4030503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and antitumor activity of spergualin analogues. II. Chemical modification of the spermidine moiety.
    Umeda Y; Moriguchi M; Kuroda H; Nakamura T; Fujii A; Iinuma H; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1987 Sep; 40(9):1303-15. PubMed ID: 3680040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor spectrum of deoxyspergualin and its lack of cross-resistance to other antitumor agents.
    Nishikawa K; Shibasaki C; Hiratsuka M; Arakawa M; Takahashi K; Takeuchi T
    J Antibiot (Tokyo); 1991 Oct; 44(10):1101-9. PubMed ID: 1955393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological activity of spergualin analogues. I.
    Nishizawa R; Takei Y; Yoshida M; Tomiyoshi T; Saino T; Nishikawa K; Nemoto K; Takahashi K; Fujii A; Nakamura T
    J Antibiot (Tokyo); 1988 Nov; 41(11):1629-43. PubMed ID: 3242505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
    Citarella RV; Wallace RE; Murdock KC; Angier RB; Durr FE; Forbes M
    Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: role of cytochrome P450 3A.
    Quintieri L; Rosato A; Napoli E; Sola F; Geroni C; Floreani M; Zanovello P
    Cancer Res; 2000 Jun; 60(12):3232-8. PubMed ID: 10866316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of antitumor activity of KW-2189, a novel water-soluble derivative of duocarmycin, against murine and human tumors.
    Kobayashi E; Okamoto A; Asada M; Okabe M; Nagamura S; Asai A; Saito H; Gomi K; Hirata T
    Cancer Res; 1994 May; 54(9):2404-10. PubMed ID: 8162588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of antitumor resistance to mouse leukemia L1210 by spergualins.
    Ishizuka M; Masuda T; Mizutani S; Osono M; Kumagai H; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1986 Dec; 39(12):1736-43. PubMed ID: 3546237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, cytotoxicity and antitumor activity of some new simplified pyrazole analogs of the antitumor agent CC-1065. Effect of an hydrophobic group on antitumor activity.
    Baraldi PG; Cacciari B; Guiotto A; Romagnoli R; Spalluto G; Zaid AN; Cozzi P; Geroni C; Mongelli N
    Farmaco; 1997 Dec; 52(12):711-6. PubMed ID: 9648274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of (-)-15-deoxyspergualin and (-)-spergualin-15-phosphate.
    Iwasawa H; Kondo S; Ikeda D; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1982 Dec; 35(12):1665-9. PubMed ID: 6926749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer activity of the structurally novel antibiotic Cl-920 and its analogues.
    Leopold WR; Shillis JL; Mertus AE; Nelson JM; Roberts BJ; Jackson RC
    Cancer Res; 1984 May; 44(5):1928-32. PubMed ID: 6546897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amino acid conferred protection against melphalan: interference with leucine protection of melphalan cytotoxicity by the basic amino acids in cultured murine L1210 leukemia cells.
    Vistica DT; Toal JN; Rabinovitz M
    Mol Pharmacol; 1978 Nov; 14(6):1136-42. PubMed ID: 732811
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.